NCT00001119 - Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV | Biotech Hunter

Enrollment

288

Participants

Timeline

Start Date

October 31, 1999

Primary Completion Date

June 30, 2004

Conditions

HIV Infections

Interventions

BIOLOGICAL

Tetanus Toxoid Vaccine

DRUG

Indinavir sulfate

DRUG

Lamivudine/Zidovudine

DRUG

Ritonavir

DRUG

Abacavir sulfate

DRUG

Amprenavir

DRUG

Efavirenz

BIOLOGICAL

Hepatitis B Vaccine (Recombinant)

DRUG

Lamivudine

DRUG

Zidovudine

Trial Locations (12)

10016

New York Univ Med Ctr, New York

10453

Bronx-Lebanon Hosp Ctr, The Bronx

55455

Univ of Minnesota, Minneapolis

60612

Univ of Illinois Chicago / Howard Brown Hlth Ctr, Chicago

94102

San Francisco Dept of Hlth / AIDS Office, San Francisco

98104

Seattle HIVNET, Seattle

Univ of Washington, Seattle

98109

Fred Hutchinson Cancer Research Ctr, Seattle

452670405

Univ of Cincinnati, Cincinnati

02115

Fenway Community Health Ctr / HIVNET, Boston

02860

Mem Hosp of Rhode Island, Pawtucket

Unknown

Saint Vincent's Hosp Med Centre, Darlinghurst

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH